drugset / Trial / NCT02284919

[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer

NCT02284919 ↗

Phase 1 Active not recruiting 30 enrolled University of Pennsylvania
NaSingle-groupOpen-labelDiagnostic

Summary

In this study, positron emission tomography (PET/CT) imaging will be used to evaluate sigma-2 (σ2) receptor activity in sites of primary breast cancer using the investigational radiotracer \[18F\]ISO-1.

Timeline

Start
2015-03-11
Primary completion
2026-11
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-ISO-1 Diagnostic / imaging agent 278 mbq Other
Subject 18F-ISO-1 Diagnostic / imaging agent 527 mbq Other

Indications